Just - Evotec Biologics
Cecile Blois currently serves as a Scientist in Antibody Discovery at Just - Evotec Biologics since October 2024, having previously held the same role from September 2021 to July 2024, where key contributions included implementing yeast display campaigns, characterizing control proteins, and optimizing mammalian cell display efforts. Prior experience includes an Associate Scientist position in Protein Engineering at Silverback Therapeutics, where construct design for antibody expression and assay development for drug candidate selection were notable achievements. Cecile's earlier roles span research associate and technician positions focused on antibody-based assays, protein engineering, and diagnostics across various organizations including RareCyte, Fred Hutchinson Cancer Research Center, and Trubion Pharmaceuticals. Educational qualifications include a BS in Biochemistry and Chemistry from the University of Washington.
This person is not in any teams
This person is not in any offices
Just - Evotec Biologics
1 followers
Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is to accelerate and expand access to biotherapeutics through scientific and technological innovation for our proprietary projects and on behalf of our partners. Learn more at www.just-evotecbiologics.com